ClinicalTrials.gov
ClinicalTrials.gov Menu

Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00524810
Recruitment Status : Completed
First Posted : September 5, 2007
Last Update Posted : June 30, 2011
Sponsor:
Information provided by:
ARCAGY/ GINECO GROUP

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2009
  Actual Study Completion Date : June 2009